Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
1.460
+0.060 (4.29%)
Nov 21, 2024, 4:00 PM EST - Market closed
Salarius Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | -6.46 | -12.54 | -31.61 | -12.77 | -7.35 | -6.94 | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 10.85 | - | - | 0.11 | Upgrade
|
| Stock-Based Compensation | 0.36 | 0.52 | 0.8 | 0.56 | 0.32 | 0.75 | Upgrade
|
| Other Operating Activities | 0.13 | 0.13 | -0.01 | -0.04 | -0.26 | -1.31 | Upgrade
|
| Change in Accounts Receivable | - | 1.48 | - | 2.25 | -3.86 | 0 | Upgrade
|
| Change in Inventory | - | - | - | - | - | 0 | Upgrade
|
| Change in Accounts Payable | -1.57 | -2.26 | 1.31 | -0.31 | -0 | -0.52 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | -0.54 | -3.47 | Upgrade
|
| Change in Other Net Operating Assets | -0.15 | -0.19 | 1.06 | 0.1 | 1.36 | -0.23 | Upgrade
|
| Operating Cash Flow | -7.69 | -12.85 | -17.6 | -10.2 | -10.31 | -11.58 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0 | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | 5.4 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -1.5 | - | - | - | Upgrade
|
| Other Investing Activities | - | - | - | - | - | 0.2 | Upgrade
|
| Investing Cash Flow | - | - | -1.5 | - | -0 | 5.61 | Upgrade
|
| Short-Term Debt Repaid | - | -0.28 | - | -0.48 | -0.97 | -0.42 | Upgrade
|
| Total Debt Repaid | -0.57 | -0.28 | - | -0.48 | -0.97 | -0.42 | Upgrade
|
| Net Debt Issued (Repaid) | -0.57 | -0.28 | - | -0.48 | -0.97 | -0.42 | Upgrade
|
| Issuance of Common Stock | - | 6.92 | 1.99 | 28.77 | 18.67 | 4.13 | Upgrade
|
| Common Dividends Paid | - | - | - | - | - | -0.13 | Upgrade
|
| Financing Cash Flow | -0.58 | 6.64 | 1.99 | 28.3 | 17.69 | 3.58 | Upgrade
|
| Net Cash Flow | -8.27 | -6.21 | -17.11 | 18.1 | 7.38 | -2.39 | Upgrade
|
| Free Cash Flow | -7.69 | -12.85 | -17.6 | -10.2 | -10.31 | -11.58 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -554.29% | -197.08% | -334.20% | Upgrade
|
| Free Cash Flow Per Share | -14.77 | -31.48 | -66.26 | -49.32 | -132.41 | -708.57 | Upgrade
|
| Cash Interest Paid | 0.02 | 0.01 | - | 0 | 0.01 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -6.13 | -8.99 | -14.37 | -3.89 | -8.77 | -4.4 | Upgrade
|
| Unlevered Free Cash Flow | -6.13 | -8.99 | -14.37 | -3.89 | -8.77 | -4.4 | Upgrade
|
| Change in Net Working Capital | 2.29 | 1.46 | -0.69 | -3.54 | 4.24 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.